大数跨境

JAK/STAT信号通路 vs 免疫 | 2024国自然放榜已多时,让天塌一会儿……

JAK/STAT信号通路 vs 免疫 | 2024国自然放榜已多时,让天塌一会儿…… 丰信生命科学
2024-09-05
2
导读:大量研究已经表明,JAK/STAT信号通路与多种疾病的发生和发展有密切关系,激活JAK/STAT通路的细胞因子包含白介素、干扰素、生长因子等家族最终影响基因的表达,所以JAK/STAT可参与炎症免疫相


免疫研究,作为2023年国自然中标数量最多的热门研究方向,和细胞信号通路JAK-STAT的关系非常密切。除了免疫,JAK/STAT与许多炎症、遗传疾病、肿瘤也有密切的相关性,在临床科学研究中,无论是机制研究还是治疗相关药物的筛选,都受到越来越多的人的关注,可谓是永不消逝的免疫相关信号,相信2024年的研究热度也不会降低。


JAK/STAT简介

JAK/STAT信号通路是一种广泛表达的细胞内信号转导通路,调控着免疫、分化、凋亡、增殖等多种细胞生物学过程[1]。涉及的关键酶包含Janus激酶(JAKs)家族、信号转导和转录激活因子(STAT)蛋白家族、细胞因子信号传导/细胞因子诱导Src同源2 (SH2)-containing (SOCS/CIS)蛋白家族的抑制因子等[2]

JAK/STAT分子通路

JAK/STAT的活化起始于细胞因子与受体的结合,招募Jak发生磷酸化,再通过SH2的介导使得STATs发生酪氨酸磷酸化并转移至细胞核中,激活特定基因的转录。

Liang, Dong et al. “JAK/STAT in leukemia: a clinical update.” Molecular cancer vol. 23,1 25. 26 Jan. 2024

JAK/STAT在疾病中作用

大量研究已经表明,JAK/STAT信号通路与多种疾病的发生和发展有密切关系,激活JAK/STAT通路的细胞因子包含白介素、干扰素、生长因子等家族最终影响基因的表达,所以JAK/STAT可参与炎症免疫相关疾病及癌症的调节。


自身免疫性疾病

在某些自身免疫性疾病中,如系统性红斑狼疮[3]和银屑病[4],JAK/STAT信号通路的异常激活与疾病的活动度和严重程度密切相关。一些先天性的免疫疾病也与JAK/STAT信号失调相关此外,JAK抑制剂也可作为这些疾病的治疗方案及媒介[5]。当机体内免疫系统失调会导致JAK/STAT通路崩溃,影响后续的基因表达,驱动T细胞白血病/淋巴瘤的发生[6]


炎症疾病

例如类风湿性关节炎、皮肤炎症、肠炎等,早有研究表明JAK抑制剂可在风湿病中发挥作用[7],研究发现阻断IL-6信号可以有效抑制一些慢性炎症[8]


癌症

在许多研究中表明,JAK/STAT通路蛋白的突变,可以导致下游基因表达激活,导致癌症产生,例如STAT3在许多癌症((膀胱癌、乳腺癌、神经癌症、结肠癌和宫颈癌等)中被激活[9]

······


JAK/STAT研究前景


目前虽然有tofacitinib和baricitinib等抑制剂的获批,但是其副作用和安全性的问题也还未解决,所以目前对于JAK/STAT通路相关抑制剂的研究也有非常大的空间[10]

如何快速研究JAK/STAT通路中细胞因子及下游疾病的关系?

RayBio JAK/STAT通路功能性微量表达蛋白多因子检测试剂盒,涵盖JAK/STAT相关152个细胞因子,可以从上游细胞因子、JAK/STAT通路因子、下游调控蛋白翻译情况多个维度评估实验样本。

可用于探究JAK/STAT相关的疾病机制、疾病抑制剂、治疗方案等方面的全面研究。

标红靶标为试剂盒涵盖的JAK/STAT部分检测因子

JAK/STAT 通路探究专用试剂

货号:AAH-BLG-JAK

检测因子数量:152(JAK/STAT通路上下游微量表达的功能性细胞因子)

技术原理:荧光标记抗原抗体结合

可选载体:载玻片

检测样本:人类血清、血浆、细胞上清、细胞裂解物、组织裂解物……

检测仪器:玻璃芯片扫描仪(Cy3荧光、分辨率≤20μm)

检测样本用量(参考,具体可以结合实际情况调整)

血清/血浆:100μL

细胞上清等无需浓缩的液体样本:1mL

细胞上清/洗液等需浓缩液体样本:10mL

组织/细胞裂解蛋白量:30μg

JAK/STAT 专用试剂盒联合检测方向

参考文献
[1]Xin P, Xu X, Deng C, et al. The role of JAK/STAT signaling pathway and its inhibitors in diseases[J] Int Immunopharmacol. 2020;80:106210.
[2]Liang, Dong et al. “JAK/STAT in leukemia: a clinical update.” Molecular cancer vol. 23,1 25. 26 Jan. 2024
[3]Reynolds, Joshua A et al. “Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum.” Journal of autoimmunity vol. 142 (2024): 103134
[4]Welsch, Katharina et al. “Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors.” European journal of immunology vol. 47,7 (2017): 1096-1107.
[5]Fischer, Marco et al. “JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.” The Journal of allergy and clinical immunology vol. 153,1 (2024): 275-286.e18
[6]Fortelny, Nikolaus et al. “JAK-STAT signaling maintains homeostasis in T cells and macrophages.” Nature immunology vol. 25,5 (2024): 847-859.
[7]Banerjee, Shubhasree et al. “JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.” Drugs vol. 77,5 (2017): 521-546. 
[8]Rose-John, Stefan et al. “The IL-6/sIL-6R complex as a novel target for therapeutic approaches.” Expert opinion on therapeutic targets vol. 11,5 (2007): 613-24.
[9]Brooks, Andrew J, and Tracy Putoczki. “JAK-STAT Signalling Pathway in Cancer.” Cancers vol. 12,7 1971. 20 Jul. 2020
[10]Xin, Ping et al. “The role of JAK/STAT signaling pathway and its inhibitors in diseases.” International immunopharmacology vol. 80 (2020): 106210.








更多专题…

来电咨询:020-31608909

















RayBio®抗体芯片近期部分学术引用

Year Journal 2023 IF Article  Title
2017 Nature Communications 16.6 Application of bio-orthogonal proteome labeling to cell transplantation and heterochronic parabiosis
2017 Nature Immunology 30.5 Direct control of regulatory T cells by keratinocytes
2017 Nature 64.8 Cytoplasmic chromatin triggers inflammation in senescence and cancer
2017 Nature Medicines 82.9 Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms
2018 Acta Biomaterialia 9.7 Manipulation of the response of human endothelial  colony-forming cells by focal adhesion assembly using gradient nanopattern plates
2018 Journal for Immuno Therapy of Cancer 10.9 Randomized phase II trial of autologous dendritic cell vaccines   versus autologous tumor cell vaccines in metastatic melanoma 5-year  follow up and additional analyses
2018 Arthritis & Rheumatology 13.3 Myogenic Progenitor Cells Exhibit Type I Interferon–Driven Proangiogenic Properties and Molecular Signature During Juvenile  Dermatomyositis
2018 Hepatology 13.5 Identification and Therapeutic Intervention of Coactivated Anaplastic Lymphoma Kinase, Fibroblast Growth Factor Receptor 2, and  Ephrin  Type-A Receptor 5 Kinases in Hepatocellular Carcinoma
2018 Hepatology 13.5 Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2
2018 Cell Host & Microbe 30.3 Listeria Adhesion Protein Induces Intestinal Epithelial Barrier Dysfunction for Bacterial Translocation 
2018 Cell 64.5 CD10+ GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness
2019 Theranostics 12.4 Monoclonal Antibody againstCXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
2019 Neurology 9.9 Changes in cerebralautoregulation and blood biomarkers after remote ischemic preconditioning
2019 Nature Communications 16.6 Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children
2019 Nature Communications 16.6 Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling
2019 Nature Cell Biology 21.3 NAD+ metabolism governs the proinflammatory  senescence-associated secretome
2019 Nature Medicine 82.9 Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
2019 Cell Research 44.1 Sodium oligomannate therapeutically remodels gutmicrobiota and suppresses gut bacterial amino acids-shaped neuroinflammation toinhibit  Alzheimer’s disease progression
2019 Cell 64.5 Regional activation of myosin II in cancer cells drives tumor  progression via a secretory cross-talk with the immune microenvironment
2020 Theranostics 12.4 Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells
2020 Theranostics 12.4 Plasma protein-based signature predicts distant metastasis and inductionchemotherapy benefit in Nasopharyngeal Carcinoma
2020 Molecular Therapy 12.4 HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis
2020 Acta Pharmaceutica Sinica B 14.5 Chrysin serves as a novel inhibitor of DGKa/FAK interaction to suppress the malignancy of esophageal squamous cellcarcinoma (ESCC)
2020 Journal of Extracellular Vesicles 16 Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innatelymphoid cell-dominant allergic airway  inflammation through delivery ofmiR-146a-5p
2020 Nature Communications 16.6 Distinct effects of generalanesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models
2020 Molecular Cell 16.6 Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment
2020 Immunity 32.4 Excessive polyamine generation in keratinocytes promotes self-RNA sensing by dendritic cells in psoriasis
2021 Pharmacological Research 9.3 Affiliated Hospital of Integrated Traditional Chinese and WesternMedicine, Nanjing University of Chinese Medicine
2021 Theranostics 12.4 Intravenous transplantationof olfactory ensheathing cells reduces neuroinflammation after spinal cordinjury via interleukin-1 receptor  antagonist
2021 Theranostics 12.4 Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
2021 Hepatology 13.5 Group-2 Innate LymphoidCells Promote Hepatocellular Carcinoma Progression via CXCL2-Neutrophil Induced Immunosuppression
2021 Nature Cell Biology 21.3 m6A-independent genome-wide METTL3 and METTL14  redistribution drives the  senescence-associated secretory phenotype
2021 Signal Transduction and Targeted Therapy 39.3 Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer
2021 Cancer Cell 50.3 Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms
2022 Journal for ImmunoTherapy of Cancer 10.9 Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
2022 PNAS 11.1 Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients
2022 Advanced Science 15.1 Mouse Modeling Dissecting Macrophage–BreastCancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis
2022 Nature Microbiology 28.3 Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions
2023 Nature Metabolism 20.8 TREM2hiresident macrophages protect the septic heart by maintaining cardiomyocyte homeostasis
2023 Journal of Hematology & Oncology 28.5 LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia
2023 Cancer Cell 50.3 Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling


RayBio®ELISA近期部分学术引用

Year Journal 2023 IF Article  Title
2017 Science Translational Medicine 17.1 Detection of early pancreatic ductal adenocarcinoma using thrombospondin-2 and CA19-9 blood markers
2017 JAMA Internal Medicine 39.0 Association of Ozone Exposure With Cardiorespiratory Pathophysiologic Mechanisms in Healthy Adults
2017 Journal of Clinical Investigation 15.9 Thrombin promotes diet-induced obesity through fibrin-driven inflammation 
2017 Nature Medicine 82.9 Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates 
2017 Nature Communications 16.6 Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis
2018 Nature 64.8 Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
2018 Autophagy 13.3 HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer 
2020  Annals of Surgery 9.0 Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
2020 Nature Communications 16.6 Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
2020 Nature Communications 16.6 Chemotaxis-driven delivery ofnano-pathogenoids for co mplete eradication oftumorspost-phototherapy
2020 Nature Communications 16.6 Receptor-targetedengineered probiotics mitigatele thal Listeria infection
2020 Brain Behavior and Immunity 15.1 Increased vulnerability to impulsive behavior after streptococcal antigen exposure and antibiotic treatment in rats
2020 Cell Metabolism 29.0 Defined p16High Senescent Cell Types Are Indispensablefor Mouse Healthspan
2020 Immunity 32.4 Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis
2020 Cell 64.5 Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures
2021 Journal of Clinical Investigation 15.9 Mutant SF3B1 promotes AKT-and NF-KB-driven mammary tumorigenesis
2022 Biomaterials 14.0 Dual-functionalhydrogel systemfor spinal cordr egeneration with sustained  releaseofarylsulfataseBalleviatesfibrotic mi croenvironment and promotes  axonalregeneration






| /15

| 6

|

|

|    






RayBiotech


RayBiotech>3SCI达到万余5万,其中CNS系列文章共计超过240篇,>55,000>15近500>20章逾170RayBiotechELISA13;单体芯片最高通量达到:定量芯片最高可检测1200个蛋白靶标,半定量芯片最高可检测8000个蛋白靶标。












【声明】内容源于网络
0
0
丰信生命科学
内容 0
粉丝 0
丰信生命科学
总阅读0
粉丝0
内容0